RecruitingRecruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
NCT06357533 · AstraZeneca
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
A Phase III, Randomised, Open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Pembrolizumab Monotherapy for the First-line Treatment of Participants With Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations (TROPION-Lung10)
About this study
This is a Phase III, randomized, open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig monotherapy compared with Pembrolizumab monotherapy for the first-line treatment of participants with locally-advanced or metastatic non-squamous NSCLC with high PD-L1 expression (TC ≥ 50%) and without actionable genomic alterations.
Eligibility criteria
Inclusion Criteria:
* Histologically or cytologically documented non-squamous NSCLC.
* Stage IIIB or IIIC or Stage IV metastatic NSCLC (according to Edition 8 of the AJCC staging manual) not amenable to curative surgery or definitive chemoradiation.
* Absence of sensitising EGFR mutations, and ALK and ROS1 rearrangements, and absence of documented local test result for any other known genomic alteration for which there are locally approved and available targeted first-line therapies.
* Must provide tumor sample to determine PD-L1 status, TROP2 status and other biomarkers.
* Known tumour PD-L1 expression status defined as TC ≥ 50%
* At least one lesion, not previously irradiated that qualifies as a RECIST 1.1 target lesion at baseline
* ECOG performance status of 0 or 1
* Adequate bone marrow reserve and organ function
Exclusion Criteria:
* Prior systemic therapy for advanced/metastatic NSCLC.
* Squamous cell histology, or predominantly squamous cell histology NSCLC; mixed small cell lung cancer; NSCLC histology, sarcomatoid variant.
* History of another primary malignancy within 3 years
* Active or prior documented autoimmune or inflammatory disorders (with exceptions)
* Any evidence of severe or uncontrolled disease that makes it undesirable for the participant to participate in the study or that would jeopardies compliance with the protocol.
* Has clinically significant third-space fluid retention (for example pleural effusion) and is not amenable for repeated drainage.
* History of any ILD/pneumonitis, including radiation pneumonitis (apart from radiation pneumonitis that did not require steroids), or drug-induced ILD/pneumonitis, has current or suspected ILD/pneumonitis that cannot be ruled out by imaging at screening.
* Has significant pulmonary function compromise, as determined by the investigator
* Spinal cord compression, or brain metastases unless participant treated and no longer symptomatic, radiologically stable, and who require no treatment with corticosteroids or anticonvulsants.
* History of leptomeningeal carcinomatosis
* Known clinically significant corneal disease
* Active infection with TB, HBV, HCV, Hepatitis A, or known HIV infection that is not well controlled
* History of active primary immunodeficiency
Study design
Enrollment target: 675 participants
Allocation: randomized
Masking: single
Age groups: adult, older_adult
Timeline
Starts: 2024-04-11
Estimated completion: 2029-12-28
Last updated: 2026-10-28
Interventions
Drug: Datopotamab DeruxtecanDrug: RilvegostomigDrug: Pembrolizumab
Primary outcomes
- • Progression-Free Survival (PFS) in TROP2 biomarker positive participants. (Approximately 4 years)
- • Overall Survival (OS) in TROP2 biomarker positive participants. (Approximately 6 years)
Sponsor
AstraZeneca · industry
With: Daiichi Sankyo
Contacts & investigators
ContactAstraZeneca Clinical Study Information Center · contact · information.center@astrazeneca.com · 1-877-240-9479
InvestigatorSuresh S. Ramalingam, MD · principal_investigator, Emory University, Atlanta, Georgia, United States of America.
All locations (290)
Research SiteRecruiting
Anchorage, Alaska, United States
Research SiteRecruiting
Tucson, Arizona, United States
Research SiteRecruiting
Little Rock, Arkansas, United States
Research SiteRecruiting
Springdale, Arkansas, United States
Research SiteRecruiting
Anaheim, California, United States
Research SiteRecruiting
Beverly Hills, California, United States
Research SiteRecruiting
Fountain Valley, California, United States
Research SiteSuspended
Newport Beach, California, United States
Research SiteRecruiting
Clermont, Florida, United States
Research SiteRecruiting
Gainesville, Florida, United States
Research SiteRecruiting
Miami Beach, Florida, United States
Research SiteRecruiting
Orange City, Florida, United States
Research SiteRecruiting
Orlando, Florida, United States
Research SiteWithdrawn
Orlando, Florida, United States
Research SiteRecruiting
West Palm Beach, Florida, United States
Research SiteSuspended
Atlanta, Georgia, United States
Research SiteRecruiting
Atlanta, Georgia, United States
Research SiteRecruiting
Atlanta, Georgia, United States
Research SiteWithdrawn
Atlanta, Georgia, United States
Research SiteRecruiting
Hinsdale, Illinois, United States
Research SiteRecruiting
Noblesville, Indiana, United States
Research SiteRecruiting
Paducah, Kentucky, United States
Research SiteRecruiting
Annapolis, Maryland, United States
Research SiteRecruiting
Boston, Massachusetts, United States
Research SiteRecruiting
Boston, Massachusetts, United States
Research SiteRecruiting
Dearborn, Michigan, United States
Research SiteRecruiting
Farmington Hills, Michigan, United States
Research SiteRecruiting
Grand Rapids, Michigan, United States
Research SiteWithdrawn
Traverse City, Michigan, United States
Research SiteRecruiting
Hattiesburg, Mississippi, United States
Research SiteRecruiting
Kansas City, Missouri, United States
Research SiteWithdrawn
Bozeman, Montana, United States
Research SiteRecruiting
Grand Island, Nebraska, United States
Research SiteRecruiting
Omaha, Nebraska, United States
Research SiteRecruiting
Las Vegas, Nevada, United States
Research SiteWithdrawn
Reno, Nevada, United States
Research SiteSuspended
Voorhees Township, New Jersey, United States
Research SiteRecruiting
Stony Brook, New York, United States
Research SiteRecruiting
Greenville, North Carolina, United States
Research SiteRecruiting
Salisbury, North Carolina, United States
Research SiteRecruiting
Cincinnati, Ohio, United States
Research SiteWithdrawn
Columbus, Ohio, United States
Research SiteRecruiting
Maumee, Ohio, United States
Research SiteRecruiting
Toledo, Ohio, United States
Research SiteWithdrawn
Portland, Oregon, United States
Research SiteRecruiting
Greenville, South Carolina, United States
Research SiteRecruiting
Sioux Falls, South Dakota, United States
Research SiteWithdrawn
Chattanooga, Tennessee, United States
Research SiteWithdrawn
Knoxville, Tennessee, United States
Research SiteRecruiting
Fort Worth, Texas, United States
Research SiteRecruiting
Houston, Texas, United States
Research SiteWithdrawn
Houston, Texas, United States
Research SiteSuspended
Houston, Texas, United States
Research SiteRecruiting
Kingwood, Texas, United States
Research SiteRecruiting
Odessa, Texas, United States
Research SiteRecruiting
Fort Belvoir, Virginia, United States
Research SiteRecruiting
Leesburg, Virginia, United States
Research SiteRecruiting
Midlothian, Virginia, United States
Research SiteRecruiting
Richmond, Virginia, United States
Research SiteRecruiting
Tacoma, Washington, United States
Research SiteRecruiting
Vancouver, Washington, United States
Research SiteRecruiting
Wenatchee, Washington, United States
Research SiteRecruiting
Appleton, Wisconsin, United States
Research SiteWithdrawn
Birtinya, Australia
Research SiteWithdrawn
Blacktown, Australia
Research SiteRecruiting
Clayton, Australia
Research SiteRecruiting
Gosford, Australia
Research SiteWithdrawn
Melbourne, Australia
Research SiteRecruiting
South Brisbane, Australia
Research SiteRecruiting
Wodonga, Australia
Research SiteRecruiting
Innsbruck, Austria
Research SiteRecruiting
Krems, Austria
Research SiteRecruiting
Linz, Austria
Research SiteRecruiting
Rankweil, Austria
Research SiteRecruiting
Vienna, Austria
Research SiteRecruiting
Vienna, Austria
Research SiteWithdrawn
Wels, Austria
Research SiteWithdrawn
Anderlecht, Belgium
Research SiteRecruiting
Bruges, Belgium
Research SiteRecruiting
Hasselt, Belgium
Research SiteRecruiting
La Louvière, Belgium
Research SiteRecruiting
Liège, Belgium
Research SiteRecruiting
Barretos, Brazil
Research SiteRecruiting
Curitiba, Brazil
Research SiteRecruiting
Florianópolis, Brazil
Research SiteRecruiting
Ipatinga, Brazil
Research SiteRecruiting
Natal, Brazil
Research SiteRecruiting
Porto Alegre, Brazil
Research SiteRecruiting
Rio de Janeiro, Brazil
Research SiteRecruiting
Santa Maria, Brazil
Research SiteRecruiting
São Paulo, Brazil
Research SiteRecruiting
Taubaté, Brazil
Research SiteRecruiting
Vancouver, British Columbia, Canada
Research SiteWithdrawn
Winnipeg, Manitoba, Canada
Research SiteRecruiting
St. John's, Newfoundland and Labrador, Canada
Research SiteRecruiting
London, Ontario, Canada
Research SiteWithdrawn
Newmarket, Ontario, Canada
Research SiteRecruiting
Oshawa, Ontario, Canada
Research SiteWithdrawn
Toronto, Ontario, Canada
Research SiteRecruiting
Lévis, Quebec, Canada
Research SiteRecruiting
Montreal, Quebec, Canada
Research SiteWithdrawn
Montreal, Quebec, Canada
Research SiteRecruiting
Montreal, Quebec, Canada
Research SiteRecruiting
Rimouski, Quebec, Canada
Research SiteRecruiting
Trois-Rivières, Quebec, Canada
Research SiteRecruiting
Saskatoon, Saskatchewan, Canada
Research SiteRecruiting
Chicoutimi, Canada
Research SiteRecruiting
Beijing, China
Research SiteRecruiting
Beijing, China
Research SiteRecruiting
Changchun, China
Research SiteRecruiting
Changsha, China
Research SiteRecruiting
Chengdu, China
Research SiteRecruiting
Chengdu, China
Research SiteRecruiting
Chongqing, China
Research SiteRecruiting
Fuzhou, China
Research SiteRecruiting
Guangzhou, China
Research SiteRecruiting
Hangzhou, China
Research SiteRecruiting
Hangzhou, China
Research SiteRecruiting
Hangzhou, China
Research SiteRecruiting
Harbin, China
Research SiteWithdrawn
Hefei, China
Research SiteRecruiting
Hefei, China
Research SiteRecruiting
Jinan, China
Research SiteWithdrawn
Jining, China
Research SiteRecruiting
Kunming, China
Research SiteRecruiting
Lanzhou, China
Research SiteRecruiting
Linhai, China
Research SiteRecruiting
Linyi, China
Research SiteRecruiting
Nanjing, China
Research SiteRecruiting
Nanning, China
Research SiteRecruiting
Nanning, China
Research SiteRecruiting
Shanghai, China
Research SiteRecruiting
Shanghai, China
Research SiteRecruiting
Shanghai, China
Research SiteRecruiting
Shenyang, China
Research SiteRecruiting
Taiyuan, China
Research SiteRecruiting
Tianjin, China
Research SiteRecruiting
Wenzhou, China
Research SiteRecruiting
Wuhan, China
Research SiteRecruiting
Wuhan, China
Research SiteRecruiting
Wuhan, China
Research SiteRecruiting
Wuhan, China
Research SiteRecruiting
Xi'an, China
Research SiteRecruiting
Yangzhou, China
Research SiteRecruiting
Zhengzhou, China
Research SiteRecruiting
Zhengzhou, China
Research SiteNot Yet Recruiting
Berlin, Germany
Research SiteRecruiting
Bonn, Germany
Research SiteRecruiting
Cologne, Germany
Research SiteWithdrawn
Düsseldorf, Germany
Research SiteRecruiting
Essen, Germany
Research SiteRecruiting
Freiburg im Breisgau, Germany
Research SiteRecruiting
Gauting, Germany
Research SiteWithdrawn
Georgsmarienhütte, Germany
Research SiteWithdrawn
Gera, Germany
Research SiteWithdrawn
Gütersloh, Germany
Research SiteRecruiting
Hamburg, Germany
Research SiteRecruiting
Hamburg, Germany
Research SiteRecruiting
Heidelberg, Germany
Research SiteSuspended
Kempten, Germany
Research SiteNot Yet Recruiting
Kiel, Germany
Research SiteSuspended
Koblenz, Germany
Research SiteWithdrawn
Ludwigsburg, Germany
Research SiteRecruiting
München, Germany
Research SiteWithdrawn
Nuremberg, Germany
Research SiteRecruiting
Potsdam, Germany
Research SiteRecruiting
Ravensburg, Germany
Research SiteRecruiting
Budapest, Hungary
Research SiteNot Yet Recruiting
Edelény, Hungary
Research SiteWithdrawn
Gyöngyös, Hungary
Research SiteRecruiting
Gyöngyös - Mátraháza, Hungary
Research SiteRecruiting
Győr, Hungary
Research SiteSuspended
Gyula, Hungary
Research SiteRecruiting
Kecskemét, Hungary
Research SiteWithdrawn
Salgótarján, Hungary
Research SiteRecruiting
Szekszárd, Hungary
Research SiteWithdrawn
Székesfehérvár, Hungary
Research SiteWithdrawn
Szolnok, Hungary
Research SiteRecruiting
Törökbálint, Hungary
Research SiteRecruiting
Chennai, India
Research SiteRecruiting
Dwārka, India
Research SiteRecruiting
Jaipur, India
Research SiteRecruiting
Kolkata, India
Research SiteWithdrawn
Marg Jaipur, India
Research SiteRecruiting
Nagpur, India
Research SiteRecruiting
Nashik, India
Research SiteRecruiting
New Delhi, India
Research SiteRecruiting
New Delhi, India
Research SiteRecruiting
Surat, India
Research SiteWithdrawn
Thiruvananthapuram, India
Research SiteRecruiting
Bergamo, Italy
Research SiteRecruiting
Genoa, Italy
Research SiteRecruiting
Milan, Italy
Research SiteRecruiting
Milan, Italy
Research SiteRecruiting
Monza, Italy
Research SiteRecruiting
Padova, Italy
Research SiteRecruiting
Pavia, Italy
Research SiteRecruiting
Ravenna, Italy
Research SiteRecruiting
Roma, Italy
Research SiteRecruiting
Rozzano, Italy
Research SiteRecruiting
Bunkyō City, Japan
Research SiteRecruiting
Bunkyō City, Japan
Research SiteRecruiting
Fukuoka, Japan
Research SiteRecruiting
Fukuoka, Japan
Research SiteRecruiting
Hakodate-shi, Japan
Research SiteRecruiting
Hidaka-shi, Japan
Research SiteRecruiting
Hirakata-shi, Japan
Research SiteRecruiting
Hirosaki-shi, Japan
Research SiteRecruiting
Hiroshima, Japan
Research SiteRecruiting
Kanazawa, Japan
Research SiteRecruiting
Kashiwa, Japan
Research SiteRecruiting
Kawasaki-shi, Japan
Research SiteRecruiting
Kumamoto, Japan
Research SiteRecruiting
Matsusaka-shi, Japan
Research SiteRecruiting
Matsuyama, Japan
Research SiteRecruiting
Nagoya, Japan
Research SiteRecruiting
Niigata, Japan
Research SiteRecruiting
Okayama, Japan
Research SiteWithdrawn
Osaka, Japan
Research SiteRecruiting
Osakasayama-shi, Japan
Research SiteRecruiting
Sagamihara-shi, Japan
Research SiteRecruiting
Sapporo, Japan
Research SiteRecruiting
Takaoka-shi, Japan
Research SiteRecruiting
Takatsuki-shi, Japan
Research SiteRecruiting
Tokushima, Japan
Research SiteRecruiting
Tokyo, Japan
Research SiteRecruiting
Utsunomiya, Japan
Research SiteRecruiting
Yokohama, Japan
Research SiteRecruiting
Olsztyn, Poland
Research SiteRecruiting
Poznan, Poland
Research SiteRecruiting
Przemyśl, Poland
Research SiteRecruiting
Warsaw, Poland
Research SiteRecruiting
Warsaw, Poland
Research SiteRecruiting
San Juan, Puerto Rico
Research SiteRecruiting
Changwon, South Korea
Research SiteRecruiting
Incheon, South Korea
Research SiteRecruiting
Seongnam-si, South Korea
Research SiteRecruiting
Seoul, South Korea
Research SiteRecruiting
Seoul, South Korea
Research SiteRecruiting
Seoul, South Korea
Research SiteNot Yet Recruiting
Seoul, South Korea
Research SiteRecruiting
Suwon, South Korea
Research SiteRecruiting
Suwon, South Korea
Research SiteRecruiting
Alicante, Spain
Research SiteRecruiting
Barcelona, Spain
Research SiteRecruiting
Barcelona, Spain
Research SiteNot Yet Recruiting
Barcelona, Spain
Research SiteRecruiting
Jerez de la Frontera, Spain
Research SiteRecruiting
Reus, Spain
Research SiteWithdrawn
Salamanca, Spain
Research SiteNot Yet Recruiting
Changhua, Taiwan
Research SiteRecruiting
Kaohsiung City, Taiwan
Research SiteRecruiting
New Taipei City, Taiwan
Research SiteRecruiting
Taichung, Taiwan
Research SiteRecruiting
Taichung, Taiwan
Research SiteRecruiting
Tainan, Taiwan
Research SiteRecruiting
Taipei, Taiwan
Research SiteRecruiting
Taipei, Taiwan
Research SiteRecruiting
Taipei, Taiwan
Research SiteRecruiting
Taipei, Taiwan
Research SiteRecruiting
Taoyuan, Taiwan
Research SiteRecruiting
Bangkok, Thailand
Research SiteRecruiting
Bangkok, Thailand
Research SiteRecruiting
Hat Yai, Thailand
Research SiteRecruiting
Muang, Thailand
Research SiteRecruiting
Mueang, Thailand
Research SiteRecruiting
Mueang, Thailand
Research SiteRecruiting
Adapazarı, Turkey (Türkiye)
Research SiteRecruiting
Ankara, Turkey (Türkiye)
Research SiteRecruiting
Ankara, Turkey (Türkiye)
Research SiteRecruiting
Antalya, Turkey (Türkiye)
Research SiteRecruiting
Diyarbakır, Turkey (Türkiye)
Research SiteRecruiting
Istanbul, Turkey (Türkiye)
Research SiteRecruiting
Istanbul, Turkey (Türkiye)
Research SiteSuspended
Cheltenham, United Kingdom
Research SiteSuspended
Inverness, United Kingdom
Research SiteWithdrawn
London, United Kingdom
Research SiteRecruiting
London, United Kingdom
Research SiteRecruiting
London, United Kingdom
Research SiteRecruiting
Norwich, United Kingdom
Research SiteRecruiting
Preston, United Kingdom
Research SiteRecruiting
Truro, United Kingdom
Research SiteRecruiting
Da Nang, Vietnam
Research SiteRecruiting
Hanoi, Vietnam
Research SiteRecruiting
Hà Nội, Vietnam
Research SiteRecruiting
Ho Chi Minh City, Vietnam
Research SiteWithdrawn
Ho Chi Minh City, Vietnam
Research SiteWithdrawn
Huế, Vietnam
Research SiteWithdrawn
Vinh, Vietnam
Research SiteRecruiting
Vĩnh Yên, Vietnam